Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial
DOI:
https://doi.org/10.1080/0284186X.2022.2079959Abstract
No abstracts available
No abstracts available
Acta Oncologica is since 1963 a forum for scientific communication across the broad field of oncology - from translational studies to survivorship aspects. From 2024 Acta Oncologica publishes research contributions with immediate Gold Open Access.
Acta Oncologica welcomes international contributions and offers global reach. Join us in publishing impactful research that advances our understanding of cancer and influences future clinical oncology.
Welcome to The European Cancer Survivorship and Rehabilitation Symposium (ECRS) 2024
Copenhagen
9-10 September 2024
Download articles from Nordic Precision Cancer Medicine, NPCM, 2023
Acta Oncologica, Online ISSN: 1651-226X
Published by Medical Journals Sweden AB (559296-5023) under the terms of the Creative Commons CC-BY 4.0 license.
Kungsängsvägen 27, 753 23 Uppsala, Sweden
Contact us